VALEANT PHARMACEUTICALS INTL
VRX
VRX was delisted on the 27th of September, 2010.
1 hedge funds and large institutions have $1.21K invested in VALEANT PHARMACEUTICALS INTL in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
61% less capital invested
Capital invested by funds: $3.11K → $1.21K (-$1.9K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TWA
TCI Wealth Advisors
Tucson,
Arizona
|
-$1K |
VRX Hedge Fund Activity: Q2 2016 in Review
1 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in VALEANT PHARMACEUTICALS INTL (VRX) for Q2 2016, worth a combined $1.21K — down 61% from $3.11K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of VRX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was TCI Wealth Advisors, exiting entirely with an estimated $1K sold.
- 1 institutional investor held VALEANT PHARMACEUTICALS INTL (VRX) as of Q2 2016, down from 2 in Q1 2016.
- Funds reported $1.21K of VALEANT PHARMACEUTICALS INTL stock for Q2 2016, down 61% quarter-over-quarter.
- 0 funds opened new VALEANT PHARMACEUTICALS INTL positions in Q2 2016 and 1 closed out, a net change of -1 holder.
- The largest VALEANT PHARMACEUTICALS INTL seller in Q2 2016 was TCI Wealth Advisors, an estimated $1K sold.
Based on aggregated 13F filings for Q2 2016.